Bedford Group Transearch Life Sciences practice congratulates Apotex on appointment of key executives

Bedford would like to congratulate Craig Yitsis on his appointment to Vice President, Global Generics Business Development and Justin Häne to the Head of Communications with Apotex.

Yitsis was most recently the Vice President of Business Development with Hikma Pharmaceuticals in Ohio. His 17+ year career spans roles with Hikma, Boehringer Ingelheim and Cardinal Health. Yitsis has a Bachelor of Science and Business Administration from Ohio State University and an MBA from Ohio University.

Häne comes to Apotex from Softchoice where he was the Head of Communications, Portfolio Marketing and Brand and previously worked in external communications with Manulife and Chief of Staff with the City of Toronto while also spending time with the Global PR and Marketing Agency; FleishmanHillard. He has a Political Science Degree from the University of Waterloo.

About Apotex

Celebrating 50 years in operation, Apotex has grown from a core generics business to a global pharmaceutical enterprise, pioneering Canadian innovation and leveraging the company’s footprint to open markets around the world.

Apotex’s purpose is to improve everyday access to affordable, innovative medicines and health products for patients and consumers worldwide. With Canadian roots and a broad portfolio of generic, biosimilar, and innovative branded products, Apotex is the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. The company’s unwavering dedication to its purpose and the healthcare community has established Apotex as a trusted partner to healthcare professionals and patients around the world.